Results 171 to 180 of about 23,150 (260)

Hydroxycarbamide and Sickle Cell Anemia: Paradoxical Effects Related to Redox Mechanisms of Cellular Adaptation. [PDF]

ACS Omega
Santana ILR, Bernardo VS, Belini Junior E, da Silva PLP, da Silva DGH, Venancio LPR.   +5 more
europepmc   +1 more source

Diagnosis of Acute Hemolytic Transfusion Reaction Caused by Cold Reactive Anti‐P1 Antibody: A Case Report

iLABMED, Volume 4, Issue 2, Page 108-112, June 2026.
A 65‐year‐old patient developed acute hemolytic transfusion reaction (AHTR) after receiving P1‐positive red blood cells. The causative anti‐P1 antibody was detectable only at 4°C, evading routine 37°C pre‐transfusion screening. This case highlights that in patients with a repeated transfusion history, dual‐temperature serological testing (37°C and 4°C)
Ke Song, Chunya Ma, Wenjia Zhang, Shilan Gao, Xin Zhang, Wei Yang, Yang Yu   +6 more
wiley   +1 more source

Assessment of the Safety and Potential Probiotic Properties of <i>Lactiplantibacillus plantarum</i> LP28 Based on Whole Genome Sequencing and Phenotypic and Oral Toxicity Analyses. [PDF]

Microorganisms
Liao YC, Cheng YC, Lee CC, Hsu HY, Cheng YF, Lin SH, Lin JS, Young SL, Watanabe K.   +8 more
europepmc   +1 more source

Variation in Chronic Automated Red Cell Exchange Practices for Sickle Cell Disease: Insights Into Isovolemic Hemodilution Use

Journal of Clinical Apheresis, Volume 41, Issue 3, June 2026.
ABSTRACT Prior surveys of chronic automated red blood cell exchange (RCE) for patients with sickle cell disease (SCD) have identified considerable procedural variability, especially with the use of isovolemic hemodilution red blood cell exchange (IHD‐RCE).
Jennifer M. Jones, Fatima Aldarweesh, Nicole Aqui, Aleh Bobr, Patricia Brunker, Mischa L. Covington, Juliana Guarente, Robert Hagar, Matthew Karafin, Divjot Singh Lamba, Grace Lee, Wen Lu, Ethan A. Mack, Gagan Muthur, Saadiya Nazli, Halima Olaniyan, Chinelo P. Onyenekwu, Jay S. Raval, Divya Setya, Yvette C. Tanhehco, Mamie Thant, Angelica Vivero, Yanyun Wu, Edward C. C. Wong, Nalan Yurtsever, Yan Zheng, Patricia A. Shi, Jennifer Webb   +27 more
wiley   +1 more source

Sutimlimab in Patients With Cold Agglutinin Disease (CAD): Results From a Managed Access Program. [PDF]

Eur J Haematol
Frey SM, Halberstadt P, Alashkar F, Lenz V, Reinhardt HC, Röth A.   +5 more
europepmc   +1 more source

Reticulated Platelets and an Optimal Model for Differentiating Thrombocytopenia Etiologies

eJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT Objectives This study aimed to investigate the clinical value of reticulated platelets (RtcPLT) percentage derived from an automated hematology analyzer in differentiating thrombocytopenia due to peripheral etiology from decreased bone marrow production (BME). In addition, a secondary objective was to establish specific reference intervals for
Tung Thanh Tran, Quyen Ngoc Truong, Hong Phuoc Mac, Thang Thanh Phan, Tai Chau Quach, Son Truong Nguyen   +5 more
wiley   +1 more source

Peripheral Blood Morphology as a Clue to 22q11.2 Deletion Syndrome. [PDF]

EJHaem
Pfeifer J, Ziegler L, Porges LS, Feldmann JL, Zaninetti C.   +4 more
europepmc   +1 more source

Targeting Middle East Respiratory Syndrome Coronavirus Spike Fusion Machinery With Antiviral Peptides: In Silico Exploration of the Heptad Repeat 2 Domain

MicrobiologyOpen, Volume 15, Issue 3, June 2026.
Griffithsin, Brevinin‐2, and CCL20 were identified as potent MERS‐CoV fusion inhibitor candidates targeting the HR2 domain through integrated molecular docking, MD simulations, and MM/PBSA analyses. These peptides demonstrated superior binding stability and favorable safety profiles compared to the standard inhibitor, supporting their potential as ...
Nasser Alotaiq, Doni Dermawan, Samir Chtita   +2 more
wiley   +1 more source